Morgan Landes is a seasoned professional in life cycle program management with extensive experience in the biopharmaceutical industry. Currently serving as Director of Life Cycle Program Management at Iovance Biotherapeutics, Inc., Morgan drives asset strategies for AMTAGVI/Lifileucel and PROLEUKIN, focusing on market optimization and project prioritization. Previous roles include Director of Portfolio Strategy and Operations at Annexon Biosciences, overseeing the strategy for neurodegenerative and ophthalmology franchises, and Associate Director of Program Management at Allogene Therapeutics, managing allogeneic CAR T cell product development. Further experience includes senior project management roles at NGM Biopharmaceuticals and BioMarin Pharmaceutical Inc., where Morgan led cross-functional teams in drug development projects across various therapeutic areas. Morgan holds a Bachelor's degree in Psychology from the University of California, Davis.
This person is not in any teams
This person is not in any offices